Abstract
reprogramming of the genome of a differentiated somatic cell nucleus, the donor nucleus 5 must be successfully introduced into the oocyte's cytoplasm, either by direct nuclear 6 injection [6, 11] , whole cell injection [19] , or most commonly, via membrane fusion by 7 electrical stimulation [1, 2, 10, 20, 21] . Despite the successes of cloning, however, overall 8 cloning efficiency [3, 22, 23] has remained low, caused to some extent by the low fusion 9 efficiencies currently achieved between the small somatic donor cell and the recipient 10 oocyte, following somatic NT [1, 3, 20] . In somatic nuclear transfer with induced fusion 11 by electrical pulse(s), the area of membrane contact between a somatic donor cell and an 12 oocyte is thought to be relatively limited, and smaller than that attained in conventional 13 NT (early NT studies with an embryonic blastomere as the nuclear donor) [21, [24] [25] [26] . 14 Therefore, an apparent obstacle to efficient somatic NT is the difficulty of fusing a tiny 15 somatic cell to a large recipient oocyte. In addition to the size disparity, the difference in 16 membrane properties among the different somatic cell types considerably affects their 17 fusion efficiency [27] . The development of cloned embryos is largely anomalous, and its 18 inefficiency could be caused by other problems inherent to the oocyte's ability to 19 completely reactivate and/or reprogram an introduced somatic genome during the cloning 20 process [22, [28] [29] [30] . 21
It is well known, that a family of lectin proteins binds carbohydrates of 22 glycoproteins in a reversible and specific manner [31, 32] squashing and compressing out the first polar body and its surrounding cytoplasm with an 22 enucleation needle (Fig. 2A) ; approximately 1/8 of the oocyte's total cytoplasmic volume 23 was extruded through a slit made on the zona pellucida [17] . Successful enucleation was 1 confirmed by fluorescent microscopy after staining with 10µg/mL Hoechst 33342. For 2 nuclear transfer, a small, round somatic donor cell (Fig. 2B) , usually with compacted 3 nucleus, was inserted into the perivitelline space of the enucleated ova (Fig. 2C) . 4
Bovine NT treatment groups were incubated for 20 min in M199-FCS 5 supplemented with 0 or 150 µg /mL phytohemagglutinin-L (PHA-L, L-4144). PHA-L 6 was classified as a lecuoagglutinin, derived from Phaseolus vulgaris (red kidney bean). 7 Donor-cytoplast complexes were incubated for 5 min in Zimmerman cell fusion medium 8
[47], then manually oriented by fine electrical rods (Fig. 2D,E ) under light microscopy. 9
Electric fusion of the donor cells to the recipient oocytes was accomplished by a double 10 electrical pulse of 2.3 kV/cm for 10 µsec. After the electric stimulation, oocyte-donor 11 cell complexes were incubated for 15 to 30 min in 20% FBS PBS at room temperature 12 before being subjected to further activation procedures. Fusion rates were determined 90 13 min after electrical pulse. 14
Activation and culture of cloned bovine embryos in vitro 15
After electrical stimulation, cloned bovine embryos were cultured in M199+FCS 16 supplemented with 2.5 µg/mL cytochalasin D (CD) (C-8273) and 10 µg/mL 17 cycloheximide (CHX) (C-6255) for 1 h, and then for an additional 4 h in M199+FCS 18 with 10 µg/mL CHX. The culture medium for bovine NT embryos was a defined CR1 19 medium (referred to as CR1aa [48]) consisting of: 114.7 mM NaCl, 3.1 mM KCl, 26.2 20 mM NaHCO 3 , 1 mM L-Glutamine, 0.4 mM sodium pyruvate (P-2256) and 5.5 mM 21 hemicalcium lactate (L-4388), and was supplemented with 1X MEM (M-7145) and 1X 22 BME amino acid (B-6766). Activated bovine NT embryos were cultured in CR1aa 23 containing 6 mg/mL BSA for 2 d (initiation of activation = day 0), under 5% CO 2 , 5% O 2 1 and 90% N 2 with high humidity. Embryos were then switched to 10% FBS CR1aa co-2 culture with a bovine cumulus monolayer for an additional 5 d. For somatic cell co-3 culture of NT embryos, the medium in the maturation droplets that contained a layer of 4 80 to 90% confluent cumulus cells was changed to the appropriate CR1aa culture 5 medium. 6
Vitrification of cloned embryos 7
Cloned bovine blastocysts on day 7, usually at the expanding stage comparable to 8 that of normally fertilized embryos, but beginning to hatch through the cuts made on the 9 zona pellucida during NT, were selected for cryopreservation. 
Evaluation of fresh and vitrified NT embryos in vitro 7
The different stages of bovine embryo development were recorded as cleavage (2 8 to 8 cell), morula, and blastocyst, on day 2, day 4, and day 7, respectively, according to 9 the standard of the International Embryo Transfer Society (IETS manual, 1998) [51] . 10
Vitrified bovine NT embryos were cultured for three days in M199 supplemented with 11 7.5%FBS. Survival and development to hatching were recorded at 0h, 24h, 48h, and 72h 12 of culture (warming = 0 h). 13
Transfer of vitrified embryos and pregnancy monitoring 14
Recipients cattle used for embryo transfer were pooled from the breeds of Chinese 15 native yellow cattle and Holstein cattle at several Chinese and Taiwanese farms. 16
Recipients were pre-screened in the farms based on the criteria of the age, health status 17 and history, size and weight, and nutritional management. The sign of onset estrus of 18 recipients was monitored closely and identified as the standing heat estrus. On day 7 after 19 standing estrus, qualified recipients were selected by palpation per rectum to verify the 20 presence and quality of functional Corpus Luteum (CL). Vitrified bovine NT embryos 21
were allocated for embryo transfer to examine their developmental potential in vivo. As a 22 control, fresh NT blastocysts, derived from fibroblasts, were loaded in straws following 23 5% CO 2 gassing of 20% FBS M199 culture medium, and transferred to a farm for direct 1 embryo transfer. Frozen NT embryos were thawed by transferring the vitrified spheres 2 containing embryos through a series of steps as described above. Two embryos were 3 transferred into each synchronous recipients by non-surgical means. Pregnancy was 4 determined by palpation per rectum on day 70 after transfer. 5
Specific experiments 6
Experiment 1: Toxicity effect of phytohemagglutinin dosage on the development of 7 parthenogenetic embryos. Parthenogenetic activation was used to examine the potential 8 toxicity of phytohemagglutinin (PHA) on embryo development in vitro. Denuded 9 metaphase II oocytes, after 24 hr of maturation, were randomly allocated to treatments 10 with PHA for 20 min at a concentration of 0, 150, 300, or 600 µg/mL in 7.5% FBS M199 11 medium. Oocytes were subsequently activated by the regime used for NT embryos. 12
Treated oocytes were cultured in CR1aa BSA/co-culture system as described above. Experiment 3: Fusion rates, and subsequent development of nuclear transfer bovine 20 embryos incubated with phytohemagglutinin. As described for Expt 3a -determining the 21 best fusion rate, somatic donor cell-cytoplast pairs were incubated with 150 µg/mL 22 phytohemagglutinin, in 7.5% FBS M199 for 0, 10, 20 or 60 min, before being subjected 23 to an electrical pulse, and the fusion rates were examined 90 min later. After determining 1 the best fusion parameters (150 µg/mL for 20 min) (Expt 3a), somatic donor cell-oocyte 2 cytoplast pairs were randomly allocated to a 2 X 2 factorial design, with 3 phytohemagglutinin treatment for 20 min at a concentration of either 0 or 150 µg/mL in 4 7.5% FBS M199, and with either cumulus or fibroblast cells as nuclear donors; 5 subsequently, the NT embryos were allocated to in vitro tests to determine their 6 developmental potentials (Expt 3b). 7
Statistical analyses 8
Each experiment was repeated four times. For each replicate, the proportions of 9 embryos from various treatments reaching cleavage and developing to 8-cell, morula, or 10 blastocyst stage, within each experiment, were determined and transformed by an arc sine 11 transformation. The transformed data then were analyzed by ANOVA (General Linear 12
Model, SPSS 11.0, Chicago, IL). For Expt 3, a two-way ANOVA (General Linear 13
Model, SPSS 11.0, Chicago, IL) with main effects and an interaction was used to analyze 14 the 2 X 2 experimental designed data [52] . A P value of less than 0.05 is considered to 15 show statistical significance. 16
Results

17
Experiment 1 18
This experiment was designed to test the effect of phytohemagglutinin (PHA) 19 dosage on oocyte survival and subsequent development. As shown in Table 1 , the 20 survival rates of oocytes were not different when treated with PHA at a dose from 0 to 21 300 µg/mL. In contrast, a PHA concentration of 600 µg/mL proved to be highly toxic to 22 oocyte development. Likewise, the total efficiency of blastocyst development was 23 similar among groups treated with 0, 150, or 300 µg/mL (28, 21, and 20% respectively, 1 P>0.05), whereas, the blastocyst development rate for oocytes treated with 600 µg/mL 2 PHA went as low as 8% (P<0.05). 3
Experiment 2 4
To further elucidate the effects of the duration of phytohemagglutinin (PHA) 5 treatment on parthenogenetic development, oocytes were treated with PHA at a dose of 6 150 µg/mL (determined in Expt 1) for 0, 10, 20 or 60 min, prior to activation . Data 7 (Table 2) showed, following PHA treatment of oocytes for 0 to 20 min, the survival (91 8 to 94%), cleavage (67 to 85%), and blastocyst development rates (23 to 38%) were not 9 affected; neither was there an adverse effect on total efficiency of blastocyst 10 development, calculated as a percentage of the total number of oocytes treated (21 to 11 35%). However, incubation with 150 µg/mL PHA for 60 min not only reduced the 12 cleavage rates (56%), as well as 8-cell (30%), morula (29%), and blastocyst development 13 (21%), but also reduced the total efficiency (19%), compared to those observed with 14 shorter treatments (P<0.05). Therefore, we conclude that a prolonged incubation with 15 phytohemagglutinin is detrimental to oocyte development, similar to the adverse effect 16 observed with a high dosage. 17
Experiment 3 18
To determine whether phytohemagglutinin had an effect on the fusion rate of 19 donor-oocyte complexes, we conducted NT followed by incubation in PHA, at a 20 concentration of 150 µg/mL, for various durations: 0, 10, 20 and 60 min (Expt 3a; same 21 as in Expt 2). The data in Fig. 1 showed that the fusion rate was not improved after a 10 22 min PHA incubation, compared to the 0 min control. In contrast, the fusion rates of 23 donor-oocyte complexes were significantly increased following a 20 min PHA treatment. 1 However, the donor-cytoplast fusion rate was not significantly improved by a prolonged 2 incubation (60 min). 3
Utilizing the optimized fusion protocol, established from the previous 4 experiments (150 µg/mL PHA for 20 min), in Exp 3b, we carried out a series of NTs to 5 examine PHA's effect on the developmental potential of NT embryos. As a 2 X2 6 factorial design, the donor cell-cytoplast pairs, after transfer with either fibroblast or 7 cumulus cells as nuclear donors (Fig. 2B) into the oocyte's subzonal spaces (Fig. 2C) , 8
were incubated for 20 min with 0 vs. 150 µg/mL phytohemagglutinin. With PHA 9 treatment a high rate (91%, n=530) of adhesion between the nuclear donor and the oocyte 10 membrane was apparently achieved (Fig. 2D) , whereas, a large number (67%,n=465) of 11 the donor-cytoplast complexes not undergoing PHA incubation showed the attachment of 12 donor cells to zona pellucida (Fig. 2E) . The results of Expt 3b (Table 3) showed that the 13 fusion rate of nuclear donors to oocyte recipients was increased after PHA treatment; 14 from 33 to 61% for skin fibroblasts, and from 59 to 88% for cumulus cells, respectively 15 (P<0.05). There were significant differences in the subsequent cleavage rates and morula 16 development among the fused embryos with phytohemagglutinin treatments. 17
Furthermore, the NT efficiency judged by the blastocyst development (Fig. 2F) over the 18 number of oocytes used, was significantly improved from 13 to 22% for skin fibroblasts, 19 and from 17 to 34% for cumulus cells when PHA was used. However, the percentage of 20 blastocyst development (29 to 38%) over the number of fused oocytes was not 21 significantly different, regardless of phytohemagglutinin treatments or donor cell type 22 (Table 3 ). The quality of NT blastocysts, estimated by their mean cell numbers (Fig. 2G)  23 was not statistically different between those PHA treated, 175 ± 5 (n=16), and the control 1 group without PHA (168 ± 7, n=21). 2
Developmental potentials of phytohemagglutinin treated NT embryos in vitro and in
vitro 2 h, the survival rates of vitrified embryos were similar (96%, P>0.05) between 8 PHA treated (n=50) and control (non-PHA treated, n=46) groups. Likewise, there were 9 no differences (P>0.05) in the hatching rates after 24, 48, 72 h culture; the hatching rates 10 were as high as 92% and 86%, from PHA-treated and control groups, respectively. 11
Embryos vitrified after NT were thawed and cultured for 2 h, to evaluate their 12 post cryopreservation viability prior to ET. After thawing, survival rates achieved with 13 PHA-treated embryos, with either cumulus (94%, n=16), or fibroblast cells (96%, n=44) 14 as nuclear donors, was similar to that of the non-treated controls (n=40) (P>0.05). Total 15 62 recipients were used for embryo transfer. Viable pregnancies, on day 70 of gestation, 16 indicated no statistically significant difference among ETs with blastocysts from: fresh 17 NT (25%, n=12), vitrified NT without PHA treatment (20%, n=20), or vitrified NT with 18 PHA treatment (17%, n=30) (P>0.05). Two female calves were born alive and healthy, 19 from fresh-NT embryos. One healthy calf was delivered from vitrified NT embryo, 20 without PHA mediated fusion. Two live, healthy calves resulted from vitrified NT 21 embryos, with PHA mediated fusion (Fig. 2H) . All cloned calves were delivered by 22
Caesarean section (C-section) on day 270 to 290 of gestation. 23
Discussion
1
In this study, we have demonstrated that the efficiency of somatic cloning can be 2 markedly increased by the use of phytohemagglutinin (PHA), presumably due to its 3 agglutinating factors that assist in the adhesion between a nuclear donor cell and the 4 recipient cytoplast. Obtaining adequate contact between a donor cell and a recipient 5 oocyte, and thereby, achieving a higher rate of fusion has been one of the challenges of 6 somatic nuclear transfer (NT). This modification of the NT procedure will help to 7 increase its overall efficiency, particularly for the cloning novices. Our study provides a 8 systematic investigation of effects of PHA dosage and duration on the efficiency of 9 bovine somatic cloning. Following PHA treatment, the fusion rates of NT donor-oocyte 10 complexes were increased from 33% to 61% for skin fibroblasts, and from 59% to 88% 11 for cumulus cells. Embryonic development of the fused clone embryos to the blastocyst 12 stage (from 29 to 38%) was not significantly affected by PHA treatment. However, the 13 overall blastocyst developmental efficiency was significantly improved following pre-14 incubation of donor-cytoplast complexes in PHA. In our study, using cumulus cells as 15 PHA before electrical fusion, and a healthy, apparently normal calf was born after the 6 resultant cloned embryos had been vitrified by opened pulled straw vitrification (OPS), 7 thawed, and transferred into recipients [42] . 8
The fusion rates in cattle, between the somatic donor cell and the recipient 9 cytoplasm vary to a great extent, depending upon the donor cell types and their origins, in most laboratories is aspiration, using a beveled glass pipette to remove both the polar 9 body and the metaphase spindles [3, 5, 39, 55, 57] . By contrast, in our study we accomplish 10 enucleation by the compressing or squashing method (Fig 2) , utilizing a glass needle 11 similar to that of Kubota et al [20, 58] . About 1/8 of the total cytoplasm is extruded out 12 through a slit on the zona pellucida to ensure a complete enucleation. We speculate that 13 the lower fusion rates reported by different laboratories are likely attributable to the 14 excess removal of cytoplasm. In addition, the high osmotic pressure of the fusion 15 medium will result in cytoplasm shrinkage, this may subsequently lead to poor cell-16 oocyte contact, and thus, insufficient fusion during electrical stimulation. 17
Our study also demonstrated that, within the appropriate dosage range and 18 incubation duration (150µg/mL for 20 min), phytohemagglutinin (PHA) showed no 19 detrimental effects on pre-implantation nor term development of NT embryos. was carried out during nuclear transfer/fusion to zona-free oocytes. This indicated that 12 PHA attachment to the cell membrane could be completed within an extremely short 13 period of time when zona-free oocytes directly contact the PHA, thus, reducing the 14 possibility of PHA toxicity. However, we believe that this hand-made cloning protocol 15 requires intensified technical skills for rapid hand-manipulations, in order to handle the 16 small donor and cytoplast pairs and to ensure their correct alignment. Our experiment 17 demonstrated that PHA could penetrate the zona pellucida, however, it required at least 18 20 min, probably to allow for absorption into the sub-zonal space, and to facilitate the 19 agglutinating process. The results of Expt 1 showed that treatments with two doses of 20 PHA (150 and 300 µg/mL) for 20 min were equally harmless to the oocytes (Table 1) . It 21 is possible that, similarly, the fusion rate could be increased by a dose of 300 µg/mL 22 PHA (for 20 min) without affecting oocyte viability. As a precaution, however, we 23 deemed it more reasonable and safer to select a regime utilizing a lower PHA dosage 1 (150 µg/mL). The development of fused NT embryos generated from PHA mediated 2 fusion was not different from those without PHA treatment in vitro, suggesting the toxic 3 effect of PHA was minimized in our system. Through a series of experiments, a 4 concentration of 150 µg/mL was found safe and effective, among all PHA treatments 5 tested, and the acceptable duration for a non-toxic, optimal fusion efficiency was 6 determined to be 20 min. [50]. In the present study, we used the same LNSV vitrification protocol for the 2 cryopreservation of PHA treated or un-treated NT embryos. Because most of the 3 embryos were half-hatched, through the slit in the zona made during the nuclear transfer 4 process, the developmental potential of cloned embryos in vitro was determined by 5 completed hatching from the zona. We observed an extremely high, up to 96%, survival 6 rate of vitrified embryos from both PHA treated and non-PHA control cloning groups, 7
and subsequent complete hatching rates of up to 86 to 92%. These results demonstrated 8 that bovine vitrified cloned embryos derived from PHA mediated fusion have equal 9 ability to survive and subsequently develop as do non-PHA treated embryos in vitro. The 10 full developmental potential and health status of newborns derived from PHA cloned 11 embryos were also shown to be similar to those from non-PHA treated embryos, 12 indicating that PHA, at the optimal dosage and incubation duration, did not have a toxic 13 effect on in vivo development of cloned embryos In conclusion, an optimized procedure 14 of somatic cloning using phytohemagglutinin (PHA) was shown to be effective by 15 significantly increasing the fusion rate, and thus, the overall efficiency of somatic cloning 16 in cattle. In vitro and in vivo development of NT embryos was not harmed by PHA 17 assisted membrane fusion treatment. This efficient cloning technology should be 18 applicable to improve nuclear transfer efficiency in other domestic animals, such as pigs, 19 sheep, rabbits, goats and horses, where electrical fusion is used. The combination of NT 20 and PHA mediated cell fusion could also be applied to the efforts to preserve endangered 21 species. 22 The overall blastocyst rate was calculated using the total number of oocytes in each treatment. 8 Bar represents 80 µm, in A, C, D, E, F, G, and 20 µm Forsythe, T, Golueke, P, Jurgella, G, Koppang, R, Lesmeister, T, Mallon, K, 39
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